About R5 Pharmaceuticals
R5 Pharmaceuticals is a company based in Nottingham (United Kingdom) founded in 2006 was acquired by Aesica in June 2010. R5 Pharmaceuticals has raised $494.31 thousand across 3 funding rounds from investors including Aesica. R5 Pharmaceuticals operates in a competitive market with competitors including Syngene, Abzena, Patheon, Piramal Group and LakePharma, among others.
- Headquarter Nottingham, United Kingdom
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of R5 Pharmaceuticals
R5 Pharmaceuticals has successfully raised a total of $494.31K across 3 strategic funding rounds. The most recent funding activity was a Grant round of $28.85 thousand completed in November 2011. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in R5 Pharmaceuticals
R5 Pharmaceuticals has secured backing from 1 investor. Prominent investors backing the company include Aesica.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Contract development and manufacturing organisation (CDMO) for APIs and finished dose forms
|
Locked | Locked | Locked |
Investor details for R5 Pharmaceuticals
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by R5 Pharmaceuticals
Investment portfolio details for R5 Pharmaceuticals
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - R5 Pharmaceuticals
Detailed financials for R5 Pharmaceuticals
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
R5 Pharmaceuticals Comparisons
Peer comparison for R5 Pharmaceuticals
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of R5 Pharmaceuticals
R5 Pharmaceuticals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Syngene, Abzena, Patheon, Piramal Group and LakePharma, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of contract research and manufacturing services for both small molecules and biologics
|
|
| Locked | Locked | Locked |
Provider of antibody discovery, cell line development, and bio analytics services
|
|
| Locked | Locked | Locked |
Commercial manufacturing and pharmaceutical development services for biopharmaceutical industry
|
|
| Locked | Locked | Locked |
Multinational conglomerate with diverse interests in Pharma, Financial Services and Real Estate
|
|
| Locked | Locked | Locked |
Provider of drug discovery on molecular biology, viral vectors and cell & protein engineering
|
|
| Locked | Locked | Locked |
Provides enabling tools and services in the life sciences research and bio-production industries
|
Detailed competitors of R5 Pharmaceuticals
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on R5 Pharmaceuticals
Complete news archive for R5 Pharmaceuticals
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about R5 Pharmaceuticals
R5 Pharmaceuticals was founded in 2006 and raised its 1st funding round 1 year after it was founded.
R5 Pharmaceuticals is headquartered in Nottingham, United Kingdom.
R5 Pharmaceuticals is a funded company, having raised a total of $494.31K across 3 funding rounds to date.
R5 Pharmaceuticals was established in 2006 in Nottingham, United Kingdom, within the pharmaceutical sector. GMP facilities were operated to produce dosage forms such as tablets, capsules, creams, ointments, and injectables, supported by an analytical laboratory for method development, quality control, and stability testing. Services were provided for formulating and analyzing synthetic and biotech materials, including cytotoxic APIs, proteins, and peptides. The company was acquired by Aesica in July 2010.
R5 Pharmaceuticals's top competitors include Abzena, Syngene and Grand River Aseptic Manufacturing.
R5 Pharmaceuticals has 1 investor. Key investors include Aesica.